These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32558640)

  • 1. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
    Ladoux A; Azoulay S; Dani C
    Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
    Ayaz S; Crea F
    Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
    [No Abstract]   [Full Text] [Related]  

  • 4. Responding to Covid-19 - A Once-in-a-Century Pandemic?
    Gates B
    N Engl J Med; 2020 Apr; 382(18):1677-1679. PubMed ID: 32109012
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies.
    Al-Tawfiq JA; Memish ZA
    Int J Antimicrob Agents; 2020 May; 55(5):105968. PubMed ID: 32259576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines.
    Liu X; Wang XJ
    J Genet Genomics; 2020 Feb; 47(2):119-121. PubMed ID: 32173287
    [No Abstract]   [Full Text] [Related]  

  • 7. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
    Calligari P; Bobone S; Ricci G; Bocedi A
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 RNA polymerase as target for antiviral therapy.
    Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
    J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World War against COVID-19: How strong is our armamentarium?
    Ramachandran V; Marimuthu RR; Chinnambedu RS
    Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: The Need for Immunoprevention at Industrial Scale.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1151. PubMed ID: 32274985
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 13. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
    Chang R; Ng TB; Sun WZ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium for the 2019 novel coronavirus.
    Gómez-Bernal G
    Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
    [No Abstract]   [Full Text] [Related]  

  • 15. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
    Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
    Molecules; 2020 May; 25(11):. PubMed ID: 32485894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging the advances in HIV for COVID-19.
    McMahon JH; Hoy JF; Kamarulzaman A; Bekker LG; Beyrer C; Lewin SR
    Lancet; 2020 Oct; 396(10256):943-944. PubMed ID: 33010825
    [No Abstract]   [Full Text] [Related]  

  • 17. Current and future therapeutical approaches for COVID-19.
    Duan Y; Yao Y; Kumar SA; Zhu HL; Chang J
    Drug Discov Today; 2020 Aug; 25(8):1545-1552. PubMed ID: 32574697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
    Polansky H; Lori G
    J Evid Based Integr Med; 2020; 25():2515690X20932523. PubMed ID: 32551855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
    Chakraborti S; Bheemireddy S; Srinivasan N
    Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection.
    Aslam M; Ladilov Y
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.